News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,373 Results
Type
Article (5018)
Company Profile (17)
Press Release (220338)
Section
Business (82259)
Career Advice (461)
Deals (15044)
Drug Delivery (8)
Drug Development (19066)
Employer Resources (30)
FDA (3677)
Job Trends (3913)
News (120176)
Policy (7503)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (293)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14805)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3696)
Artificial intelligence (41)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2875)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (449)
Cardiovascular disease (23)
Career advice (393)
Career pathing (3)
CAR-T (31)
Cell therapy (102)
Cervical cancer (2)
Clinical research (16034)
Collaboration (169)
Compensation (169)
Complete response letters (2)
COVID-19 (302)
CRISPR (7)
C-suite (104)
Cystic fibrosis (16)
Data (513)
Depression (5)
Diabetes (42)
Diagnostics (2042)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40822)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37795)
Executive appointments (311)
FDA (3930)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (15)
Generative AI (2)
Gene therapy (50)
GLP-1 (108)
Government (411)
Guidances (17)
Healthcare (5056)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (318)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7824)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (49)
MASH (28)
Medical device (3861)
Medtech (3862)
Mergers & acquisitions (7425)
Metabolic disorders (122)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (1)
Neuroscience (340)
NextGen: Class of 2025 (1681)
Non-profit (727)
Northern California (925)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (12)
Pancreatic cancer (14)
Parkinson's disease (27)
Partnered (4)
Patents (21)
Patient recruitment (29)
Peanut (5)
People (24603)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4777)
Phase II (6961)
Phase III (5553)
Pipeline (551)
Policy (9)
Postmarket research (625)
Preclinical (1868)
Press Release (66)
Prostate cancer (28)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (67)
Real estate (1874)
Recruiting (8)
Regulatory (5117)
Reports (14)
Research institute (304)
Resumes & cover letters (68)
Rett syndrome (3)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Southern California (699)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1009)
Stomach cancer (1)
Supply chain (10)
Tariffs (4)
United States (7029)
Vaccines (36)
Venture capitalists (2)
Weight loss (21)
Women's health (1)
Date
Today (50)
Last 7 days (166)
Last 30 days (735)
Last 365 days (10027)
2025 (2985)
2024 (11038)
2023 (13202)
2022 (18679)
2021 (19700)
2020 (18260)
2019 (13236)
2018 (10245)
2017 (10009)
2016 (9166)
2015 (12123)
2014 (9588)
2013 (7715)
2012 (8334)
2011 (8797)
2010 (8639)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11454)
Australia (1609)
California (1940)
Canada (700)
China (71)
Colorado (82)
Connecticut (91)
Delaware (31)
Europe (24516)
Florida (274)
Georgia (33)
Idaho (23)
Illinois (112)
India (7)
Indiana (64)
Iowa (1)
Japan (72)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (221)
Massachusetts (1552)
Michigan (85)
Minnesota (139)
Mississippi (1)
Missouri (22)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (15)
New Jersey (560)
New Mexico (5)
New York (470)
North Carolina (326)
North Dakota (2)
Northern California (925)
Ohio (56)
Oklahoma (5)
Oregon (4)
Pennsylvania (345)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (699)
Tennessee (40)
Texas (228)
Utah (60)
Virginia (46)
Washington D.C. (9)
Washington State (174)
West Virginia (2)
Wisconsin (22)
225,373 Results for "cerner corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Cerner Enviza Collaborates with FDA to Develop Innovative AI Tools for Drug Safety and Real-World Evidence Studies
Cerner Enviza, an Oracle company, along with John Snow Labs, are now helping support the U.S. Food and Drug Administration’s drug safety Sentinel Initiative.
April 10, 2023
·
3 min read
Deals
Oracle Purchase of Cerner Approved
Oracle Corporation announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance.
June 1, 2022
·
7 min read
BioMidwest
Cerner’s New President and CEO to Kick Off Annual Cerner Health Conference
Cerner Corporation, a global healthcare technology company, will host its annual Cerner Health Conference, next week, Oct. 12-13, kicking off with Dr. David Feinberg, Cerner’s new president and CEO.
October 7, 2021
·
3 min read
Business
CERNER REPORTS FIRST QUARTER 2022 RESULTS
Cerner Corporation (Nasdaq: CERN) today announced results for the 2022 first quarter that ended March 31, 2022.
May 3, 2022
·
1 min read
Business
Cerner Collaboration to Increase Access to Cancer Clinical Trials
Cerner Corporation (NASDAQ: CERN), Elligo Health Research® and Freenome are collaborating to enable a clinical trial through the Learning Health Network to help advance early cancer detection.
May 18, 2022
·
4 min read
Business
Cerner Reports Fourth Quarter And Full Year 2021 Results
Cerner Corporation announced results for the 2021 fourth quarter and full year that ended Dec. 31, 2021.
February 22, 2022
·
1 min read
Business
Cerner Announces Quarterly Dividend - Mar 15, 2022
Cerner Corporation, a global healthcare technology company, announced that its Board of Directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share.
March 15, 2022
·
6 min read
BioMidwest
The International Gaucher Alliance and Cerner Enviza Enroll First Patient In GARDIAN Registry
The International Gaucher Alliance and Cerner Corporation announce that the GARDIAN registry is now open for registrations, and the first patient has already enrolled April 25, 2022.
April 26, 2022
·
4 min read
Business
Cerner Reports Third Quarter 2021 Results
Cerner Corporation (Nasdaq: CERN) today announced results for the 2021 third quarter that ended September 30, 2021.
October 29, 2021
·
1 min read
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
1 of 22,538
Next
